Inhibition of Vesicular Stomatitis Virus by Kethoxal Bis (Thiosemicarbazone)

References

1. Bauer D. J., sadler P. W. 1960; The structure-activity relationships of the antiviral chemotherapeutic activity of isatin β-thiosemicarbazones. British Journal of Pharmacology 15:101–110
   [Google Scholar]
2. Bauer D. I., Apostolov K., Selway J. W. T. 1970; Activity of methisazone against RNA viruses. Annals of the New York Academy of Sciences 173:314–319
   [Google Scholar]
3. Bonner W. M., Laskey R. A. 1974; A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. European Journal of Biochemistry 46:83–88
   [Google Scholar]
4. Booth B. A., Sartorelli A. C. 1967; Metabolic effects of copper in intact cells: comparative activity of cupric chloride and the cupric chelate of kethoxal bis (thiosemicarbazone). Molecular Pharmacology 3:290–302
   [Google Scholar]
5. Booth B. A., Moore E. C., Sartorelli A. C. 1971; Metabolic effects of some tumor-inhibitory pyridine carboxaldehyde thiosemicarbazones. Cancer Research 31:228–234
   [Google Scholar]
6. Campbell J. B., Maes R. F., Wiktor T. J., Koprowski H. 1968; The inhibition of rabies virus by arabinosy cytosine. Studies on the mechanism and specificity of action. Virology 34:701–708
   [Google Scholar]
7. Crim J. A., Petering H. G. 1967; The antitumor activity of Cu (Ⅱ) KTS, the copper (Ⅱ) chelate of 3-ethoxy-2-oxobutyraldehyde bis (thiosemicarbazone). Cancer Research 27:1278–1285
   [Google Scholar]
8. Flamand A., Eishop D. H. L. 1974; In vivo synthesis of RNA by vesicular stomatitis virus and its mutants. Journal of Molecular Biology 87:31–53
   [Google Scholar]
9. Follett E. A. C., Pringle C. R., Winner W. H., Skehel J. J. 1974; Virus replication in enucleate cells: vesicular stomatitis virus and influenza virus. Journal of Virology 13:394–399
   [Google Scholar]
10. Haase A. T., Levinson W. 1973; Inhibition of RNA slow viruses by thiosemicarbazones. Biochemical and Biophysical Research Communications 51:875–880
    [Google Scholar]
11. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T₄. Nature, London 227:680–685
    [Google Scholar]
12. Levinson W. 1967; Fragmentation of the nucleus in Rous sarcoma virus infected chick embryo cells. Virology 32:74–83
    [Google Scholar]
13. Levinson W. 1973; Inhibition of viruses, tumors and pathogenic micro-organisms by isatin β-thiosemi-carbazone and other thiosemicarbazones. In Selective Inhibitors of Viral Function pp 213–226 Edited by Carter W. Cleveland: CRC Press;
    [Google Scholar]
14. Levinson W., Helling R. 1976; Inactivation of lambda phage infectivity and lambda deoxyribonucleic acid transfection by TV-methyl isatin betathiosemicarbazone. Antimicrobial Agents and Chemotherapy 9:160–163
    [Google Scholar]
15. Levinson W., Coleman V., Woodson B., Rabson A., Lanier J., Whitcher J., Dawson C. 1974; Inactivation of herpes simplex virus by thiosemicarbazone and certain cations. Antimicrobial Agents and Chemotherapy 5:398–402
    [Google Scholar]
16. Levinson W., Faras A., Morris R., Mikelens P., Ringold G., Kass S., Levinson B., Jackson J. 1973a; Effect of N-methyl isatin betathiosemicarbazone on Rous sarcoma virus, several isolated enzymes and other viruses. In ICN-UCLA Symposium on Virus Research pp 403–409 Edited by Fox F., Robinson W. New York: Academic Press;
    [Google Scholar]
17. Levinson W., Faras A., Woodson B., Jackson J., Bishop J. 1973b; Inhibition of RNA dependent DNA polymerase of Rous sarcoma virus by thiosemicarbazones and several cations. Proceedings of the National Academy of Sciences of the United States of America 70:164–168
    [Google Scholar]
18. Levinson W., Woodson B., Jackson J. 1971; Inactivation of Rous sarcoma virus on contact with TV-substituted isatin beta-thiosemicarbazone. Nature New Biology 232:116–118
    [Google Scholar]
19. Levy J., Levy, S., Levinson W. 1976; Inactivation of murine RNA tumor viruses by isatin betathiosemicarbazone, its derivative and analogs. Virology 74:426–431
    [Google Scholar]
20. Loening U. R. 1969; Determination of the molecular weight of RNA by polyacrylamide gel electrophoresis. Biochemical Journal 113:131–138
    [Google Scholar]
21. Logan J. C., Fox M. P., Morgan J. H., Makohon A. M., Pfau C. J. 1975; Arena virus inactivation on contact with N-substituted isatin beta-thiosemicarbazone and certain cations. Journal of General Virology 28:271–284
    [Google Scholar]
22. Mikelens P., Woodson B., Levinson W. 1976; Association of nucleic acids with complexes of N-methyl isatin beta-thiosemicarbazone and copper. Biochemical Pharmacology 26:821–827
    [Google Scholar]
23. Pearson G. D., Zimmerman E. F. 1969; Inhibition of poliovirus replication by TV-methyl isatin B-4′-4′ dibutyl thiosemicarbazone. Virology 38:641–650
    [Google Scholar]
24. Repik P., Flamand A., Bishop D. H. L. 1974; Effect of interferon upon the primary and secondary transcription of vesicular stomatitis and influenza viruses. Journal of Virology 14:1169–1178
    [Google Scholar]
25. Schincariol A. L., Howatson A. F. 1970; Replication of vesicular stomatitis virus. Virology 42:732–743
    [Google Scholar]
26. Studier F. W. 1973; Analysis of bacteriophage T7 early RNA’s and proteins on slab gels. Journal of Molecular Biology 79:237–248
    [Google Scholar]
27. Turner W., Bauer D., Nimmo-Smith R. H. 1962; Eczema vaccinatum treated with TV-methyl isatin β-thiosemicarbazone. British Medical Journal i:1317–1319
    [Google Scholar]
28. van Giessen G. T., Petering H. G. 1968; Metal complexes of 3-ethoxy-2-oxo-butyraldehyde bis (thiosemicarbazone) and related ligands as antitumor agents. Journal of Medicinal Chemistry 11695–699
    [Google Scholar]